Siga Appeals $2.8B Drug-Contract Disqualification
Siga Technologies Inc. is planning to appeal a U.S. Small Business Administration ruling that declared it too large to receive a small-business set-aside contract for smallpox antivirals due to questions about...To view the full article, register now.
Already a subscriber? Click here to view full article